Temozolomide as salvage treatment in primary brain lymphomas-Reference-Cited by-同舟云学术

Temozolomide as salvage treatment in primary brain lymphomas

Published:2007-02-27 Issue:6 Volume:96 Page:864-867
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Reni M,Zaja F,Mason W,Perry J,Mazza E,Spina M,Bordonaro R,Ilariucci F,Faedi M,Corazzelli G,Manno P,Franceschi E,Pace A,Candela M,Abbadessa A,Stelitano C,Latte G,Ferreri A J M

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6603660.pdf

Reference13 articles.

1. Abrey LE, Batchelor TT, Ferreri AJM, Gospodarowicz M, Pulczynski EJ, Zucca E, Smith JR, Korfel A, Soussain C, DeAngelis LM, Neuwelt EA, O'Neill BP, Thiel E, Shenkier T, Graus F, Van den Bent M, Seymour JF, Poortmans P, Armitage JO, Cavalli F (2005) Report of an international Workshop to Standardize Baseline Evaluation and response criteria for primary CNS lymphoma. J Clin Oncol 23: 5034–5043

2. Arellano-Rodrigo E, Lopez-Guillermo A, Bessell EM, Nomdedeu B, Montserrat E, Graus F (2003) Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma. Eur J Haematol 70: 219–224

3. Enting RH, Demopoulos A, DeAngelis LM, Abrey L (2004) Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide. Neurology 63: 901–903

4. Ferreri AJ, Abrey LE, Blay JY, Borisch B, Hochman J, Neuwelt EA, Yahalom J, Zucca E, Cavalli F, Armitage J, Batchelor T (2003) Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15 2002. J Clin Oncol 21: 2407–2414

5. Ferreri AJM, Reni M, Pasini F, Calderoni A, Tirelli U, Pivnik A, Aondio GM, Ferrarese F, Gomez H, Ponzoni M, Borisch B, Berger F, Chassagne C, Iuzzolino P, Carbone A, Weis J, Pedrinis E, Motta T, Jouvet A, Barbui T, Cavalli F, Blay JY, for the International Extranodal Lymphoma Study Group (2002) A multicenter study of treatment of primary CNS lymphoma. Neurology 58: 1513–1520

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of first-line combination therapy versus monotherapy for vitreoretinal lymphoma: a systematic review and meta-analysis;BMC Ophthalmology;2023-11-22

2. Preclinical and clinical evaluation of Buparlisib (BKM120) in recurrent/refractory Central Nervous System Lymphoma;Leukemia & Lymphoma;2023-06-15

3. Efficacy and safety of first-line combination therapy versus monotherapy for vitreoretinal lymphoma: A systematic review and meta-analysis;2023-05-22

4. Diagnosis and management of vitreoretinal lymphoma: present and future treatment perspectives;Japanese Journal of Ophthalmology;2023-05-20

5. EBV and Lymphomagenesis;Cancers;2023-04-04